Enzon Pharmaceuticals, Inc. (ENZN)
OTCMKTS · Delayed Price · Currency is USD
0.0601
+0.0048 (8.68%)
Feb 26, 2026, 3:58 PM EST
Enzon Pharmaceuticals Market Cap
Enzon Pharmaceuticals has a market cap or net worth of $4.46 million as of February 26, 2026. Its market cap has decreased by -58.55% in one year.
Market Cap
4.46M
Enterprise Value
5.28M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
Market Cap Chart
Since January 16, 1990, Enzon Pharmaceuticals's market cap has decreased from 108.08M to 4.46M, a decrease of -95.87%. That is a compound annual growth rate of -8.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 4.10M | 45.91% |
| Dec 31, 2025 | 2.81M | -75.72% |
| Dec 31, 2024 | 11.58M | 66.86% |
| Dec 29, 2023 | 6.94M | -62.07% |
| Dec 30, 2022 | 18.31M | -27.99% |
| Dec 31, 2021 | 25.42M | 37.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orgenesis | 5.65M |
| GPL Holdings | 5.38M |
| Nymox Pharmaceutical | 5.13M |
| Mosaic ImmunoEngineering | 5.10M |
| Bioxytran | 4.80M |
| AXIM Biotechnologies | 4.14M |
| Clearside Biomedical | 3.44M |
| Burzynski Research Institute | 3.42M |